Arnhold LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.7M | Hold |
391,005
| – | – | 1.74% | 15 |
|
|
2025
Q4 | $21.1M | Hold |
391,005
| – | – | 1.6% | 15 |
|
|
2025
Q3 | $17.6M | Sell |
391,005
-2,991
| -0.8% | -$140K | 1.47% | 22 |
|
|
2025
Q2 | $18.2M | Hold |
393,996
| – | – | 1.66% | 19 |
|
|
2025
Q1 | $24M | Sell |
393,996
-41,310
| -9% | -$2.41M | 2.43% | 9 |
|
|
2024
Q4 | $24.6M | Sell |
435,306
-36,634
| -8% | -$2.05M | 2.43% | 9 |
|
|
2024
Q3 | $24.4M | Sell |
471,940
-30,823
| -6% | -$1.45M | 2.37% | 11 |
|
|
2024
Q2 | $20.9M | Buy |
502,763
+146,070
| +41% | +$6.54M | 2.2% | 11 |
|
|
2024
Q1 | $19.3M | Buy |
356,693
+36,890
| +12% | +$1.88M | 2.05% | 17 |
|
|
2023
Q4 | $16.4M | Buy |
319,803
+64,533
| +25% | +$3.39M | 1.83% | 18 |
|
|
2023
Q3 | $14.8M | Buy |
255,270
+23,535
| +10% | +$1.44M | 1.77% | 21 |
|
|
2023
Q2 | $14.8M | Sell |
231,735
-1,926
| -0.8% | -$129K | 1.68% | 21 |
|
|
2023
Q1 | $16.2M | Buy |
233,661
+4,610
| +2% | +$325K | 1.84% | 16 |
|
|
2022
Q4 | $16.5M | Sell |
229,051
-9,899
| -4% | -$746K | 2.02% | 10 |
|
|
2022
Q3 | $17M | Hold |
238,950
| – | – | 2.28% | 10 |
|
|
2022
Q2 | $18.4M | Sell |
238,950
-70,157
| -23% | -$5.34M | 2.2% | 11 |
|
|
2022
Q1 | $22.6M | Sell |
309,107
-128,610
| -29% | -$8.64M | 2.54% | 6 |
|
|
2021
Q4 | $27.3M | Buy |
437,717
+127,492
| +41% | +$7.48M | 3.09% | 4 |
|
|
2021
Q3 | $18.4M | Buy |
310,225
+4,633
| +2% | +$305K | 2.12% | 10 |
|
|
2021
Q2 | $20.4M | Sell |
305,592
-500
| -0.2% | -$32.6K | 2.31% | 11 |
|
|
2021
Q1 | $19.3M | Buy |
306,092
+100
| +0% | +$6.22K | 2.32% | 9 |
|
|
2020
Q4 | $19M | Sell |
305,992
-152
| -0% | -$9.35K | 2.46% | 7 |
|
|
2020
Q3 | $18.5M | Hold |
306,144
| – | – | 2.73% | 6 |
|
|
2020
Q2 | $18M | Buy |
306,144
+43,558
| +17% | +$2.61M | 2.86% | 4 |
|
|
2020
Q1 | $14.6M | Buy |
262,586
+23,453
| +10% | +$1.43M | 2.7% | 4 |
|
|
2019
Q4 | $15.3M | Sell |
239,133
-107,174
| -31% | -$6.14M | 2.42% | 6 |
|
|
2019
Q3 | $17.6M | Buy |
346,307
+17,613
| +5% | +$828K | 2.98% | 6 |
|
|
2019
Q2 | $14.9M | Buy |
328,694
+54,335
| +20% | +$2.53M | 2.61% | 6 |
|
|
2019
Q1 | $13.1M | Buy |
274,359
+63,231
| +30% | +$3.15M | 2.36% | 8 |
|
|
2018
Q4 | $11M | Buy |
211,128
+43,694
| +26% | +$2.35M | 2.04% | 11 |
|
|
2018
Q3 | $10.4M | Sell |
167,434
-11,595
| -6% | -$688K | 1.79% | 16 |
|
|
2018
Q2 | $9.91M | Buy |
179,029
+67,500
| +61% | +$3.65M | 1.74% | 13 |
|
|
2018
Q1 | $7.05M | Buy |
+111,529
| New | +$7.17M | 1.33% | 22 |
|
Other funds holding BMY
VCM
VPM
Arnhold LLC's BMY Position: Q1 2026 in Review
Arnhold LLC held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 391,005 shares worth $23.7M. The position accounts for 1.74% of the portfolio, ranked #15.
Arnhold LLC first reported a position in BMY in Q1 2018 and has held it in 33 quarters since. The position peaked at $27.3M in Q4 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Arnhold LLC held 391,005 shares of Bristol-Myers Squibb worth $23.7M as of Q1 2026.
- Arnhold LLC left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 1.74% of Arnhold LLC's portfolio in Q1 2026, its #15 holding.
- Arnhold LLC first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 33 quarters since.
- Arnhold LLC's Bristol-Myers Squibb position peaked at $27.3M in Q4 2021.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Arnhold LLC's 13F filing for Q1 2026, filed 11 May 2026.